Tag: FDA
-

FDA’s New Labeling: No More Black Box Warnings for Menopause Hormone Therapy
Overview: A Shift in How Menopause Hormone Therapy Is Labeled The FDA has announced a major update to the labeling of menopause hormone therapies, removing the long-standing black box warnings about potential risks such as breast cancer, heart disease, and dementia. The change aims to provide clearer, more balanced information to patients and clinicians, emphasizing…
-

FDA Moves to Remove Black Box Warnings From Menopause Hormone Therapies
FDA Announces Removal of Black Box Warnings From Menopause Hormone Therapies The U.S. Food and Drug Administration (FDA) has announced plans to remove the black box warnings associated with menopause hormone therapies. These warnings, once highlighted as the most serious safety information on medication labels, detailed potential risks related to breast cancer, heart disease, and…
-

FDA Softens Stance on Menopause Hormone Therapies: What Changed and Why
What the FDA decision means for menopause treatment The U.S. Food and Drug Administration has announced a pivotal update to the labeling of menopause hormone therapies (HRT). Historic labels carried a black box warning about several serious health risks, including breast cancer, heart disease, and dementia. The FDA’s new approach no longer uses that singular,…
-

Cops on Ketamine: Unregulated Mental Health Treatments for First Responders
Ketamine and the push to help first responders When mental health crises collide with high-stress public service, innovative treatments often move faster than policy and regulation. Ketamine-assisted psychotherapy—combining a dissociative drug with guided talk therapy—has emerged as a potential option for police officers, firefighters, and military personnel who carry heavy trauma loads. In rural western…
-

Medicine Security in the Philippines: A Public-Private Push to Strengthen Local Pharma and Cut Import Dependence
Overview: A turning point for Philippine medicine security The Philippines is intensifying its focus on medicine security as a matter of public health and national resilience. In a high-profile public forum organized by the Philippine Chamber of Pharmaceutical Industries (PCPI), key lawmakers, regulators, and industry leaders outlined concrete reforms and partnerships designed to reduce import…
-

Medicine Security in the Philippines: Strengthening Public-Private Partnerships
Overview: A National Push for Medicine Security The Philippines is taking concrete steps to strengthen its medicine security in the post-pandemic era. A recent public forum organized by the Philippine Chamber of Pharmaceutical Industries (PCPI) focused on how targeted reforms and robust public-private partnerships can bolster domestic pharmaceutical capacity and reduce heavy reliance on imports.…
-

Philippines strengthens medicine security through bold public-private partnerships
Public-Private Partnership as the Core of Philippines’ Medicine Security The Philippines is stepping up its strategy to safeguard medicine access in the post-pandemic era. Stakeholders across government and industry gathered under the banner of the Philippine Chamber of Pharmaceutical Industries (PCPI) to discuss concrete measures aimed at strengthening domestic pharmaceutical capacity and reducing import dependence.…



